Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 17th June 2021
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

VMD recalls chicken vaccine over efficacy concerns
The VMD has issued a product recall alert for a single batch of Salmovac 400.
Veterinary surgeons urged to examine their inventories immediately.

The Veterinary Medicines Directorate (VMD) has issued a product recall alert for a batch of Salmovac 440, manufactured by CEVA Animal Health, over concerns about its efficacy.

Salmovac 440 is used in chickens to protect them against Salmonella Enteritidis and Salmonella Typhimurium. Usually administered via drinking water, it contains the contains the live Salmonella Enteritidis strain in freeze-dried form. 

The VMD writes: ‘We wish to make veterinary surgeons aware that Ceva Animal Health Ltd has initiated a Class II recall to veterinary level for the product Salmovac 440.

‘Following testing Ceva Animal Health Ltd have confirmed that Batch No. 3000520B with an Expiry date of 11 December 2021 has live bacterial count values (potency) below the authorised specification and there is potential for a lack of efficacy.

‘Ceva Animal Health Ltd is contacting veterinary surgeons to examine inventory immediately and quarantine products subject to this recall.’

Further information about the recall is available from Ms Helen Houghton, poultry business unit manager, on 01494 781510. 

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.